Thursday, November 26, 2020
Home Tags Personalised medicine

personalised medicine Related News

UK poises to take global lead in genomics with new strategy

UK poises to take global lead in genomics with new strategy

A new landmark strategy has been launched that aims to secure the UK as a future global leader in genomics. The new National Genomic Healthcare...
Artificial Intelligence tool shows 50% COVID-19 mortality reduction

Artificial Intelligence tool shows 50% COVID-19 mortality reduction

The use of an Artificial Intelligence (AI) tool aiding personalised COVID-19 treatment decisions has been shown to lead to a 50% reduction in COVID-19...
CBD’s therapeutic benefits help loosen regulatory constraints

CBD’s therapeutic benefits help loosen regulatory constraints

Most regions that have approved medical cannabis typically see doctors prescribe CBD-based medications to their patients. CBD's therapeutic benefits have thrust the compound into the...
NHS North East partners with Health Call to deliver digital healthcare

NHS North East partners with Health Call to deliver digital healthcare

NHS organisations across the UK have welcomed a new collaboration to harness innovative digital healthcare and technology, with the aim of improving patient health...
How pre-filled syringes are helping to deliver the personalised drug revolution

How pre-filled syringes are helping to deliver the personalised drug revolution

With ‘novel’ biologic and personalised drugs being used to treat and cure chronic ailments, discover how pre-filled syringes are set to gain high traction...
BRoTHER – Can digitalisation improve the interaction of tissue biobanks?

BRoTHER – Can digitalisation improve the interaction of tissue biobanks?

How can digitalisation support interactions between tissue biobanks, and why is this important? The BRoTHER project may have the answers. The project BRoTHER (Biobank Research...
The digital revolution of biobanks: what role is precision medicine playing?

The digital revolution of biobanks: what role is precision medicine playing?

Precision medicine is forcing modern biobanks to shift their focus from sample-driven to data-driven strategies, the IARC’s Zisis Kozlakidis tells Health Europa. 20 years ago,...
Genomic testing is changing the way prostate cancer is diagnosed

Genomic testing is changing the way prostate cancer is diagnosed

MDxHealth has developed the most comprehensive solution for diagnosing prostate cancer, shifting treatment from a generic approach to a more personalised method. Across Europe and...
Metastasis in prostate cancer can now be predicted

Metastasis in prostate cancer can now be predicted

Scientists have created a cheaper, faster, reproducible diagnostic technique that has the potential to predict the risk of metastasis in prostate cancer. For patients who...
Is personalised medicine for neurodegenerative disorders on the horizon?

Is personalised medicine for neurodegenerative disorders on the horizon?

According to UT Southwestern, USA, new discoveries focusing on neurodegenerative disorders predict ability to forecast dementia from a single molecule. By recently identifying the molecular...
5th Precision Medicine and Biomarkers Leaders Summit: Europe

5th Precision Medicine and Biomarkers Leaders Summit: Europe

Health Europa listened to InnVentis CEO Thomas Wilckens discuss some of the diagnostic and data challenges involved in precision medicine. The 5th Precision Medicine and...
Bar-Ilan University: Nano-Institute at the cutting edge of medical research

Bar-Ilan University: Nano-Institute at the cutting edge of medical research

Offering a glimpse into breakthrough research, Health Europa explores with Bar-Ilan University, their Nanotechnology Institute that’s advancing medicine. The Institute for Nanotechnology and Advanced Materials...
Towards personalised medicine: Artificial Intelligence in cancer

Towards personalised medicine: Artificial Intelligence in cancer

Dr Andrea Sottoriva introduces REVOLVER and considers the wider application of Artificial Intelligence in cancer research and care. Developed by scientists at The Institute of...
Sustainability in biobanking: a perspective from ISBER

Sustainability in biobanking: a perspective from ISBER

Zisis Kozlakidis, the past president of the International Society for Biological and Environmental Repositories, considers how to effectively confront the challenge of sustainability in...
Artificial Intelligence brings personalised cancer treatment one step closer

Artificial Intelligence brings personalised cancer treatment one step closer

Personalised cancer treatment could soon become a reality thanks to a new Artificial Intelligence (AI) technique that can predict how tumours will progress and...
Gender and BMI could help avoid harmful side effects in Type 2 diabetes

Gender and BMI could help avoid harmful side effects in Type 2 diabetes

Factoring in simple characteristics such as sex and BMI can help clinicians make a decision on the correct drug to prescribe and improve control...
The Precision Medicine and Biomarkers Leaders Summit 2018

The Precision Medicine and Biomarkers Leaders Summit 2018

Leading pharmaceutical and biotech companies worldwide are gathering for the Precision Medicine and Biomarkers Leaders Summit 2018. We provide an overview of the event. In...
Bar-Ilan University: a habitat for interdisciplinary science

Bar-Ilan University: a habitat for interdisciplinary science

Professor Shulamit Michaeli presents Bar-Ilan University, a Tel Aviv-based university boasting big ambitions, unparalleled achievements, and ever-increasing academic prowess. Bar-Ilan University (BIU), located in the...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest